- Hem
- Om universitetet
- Hitta person
- Dan Lind
Dan Lind
Forskare, biträdande
Avd för medicinsk kemi och cellbiologiDoktorand
Avd för medicinsk kemi och cellbiologi-
Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell
growth
Wei-Yun Lai, Tzu-Po Chuang, Marcus Borenäs, Dan E. Lind, Bengt Hallberg, Ruth H. Palmer
CELL DEATH AND DIFFERENTIATION - 2024 -
Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in
Mice
Mara Caputo, Emma Andersson, Ying Xia, Wei Hou, Emmelie Cansby, Max Erikson, Dan E. Lind, Bengt Hallberg, Manoj Amrutkar, Margit Mahlapuu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 2024 -
Synergistic antitumor effects of Lorlatinib and 177Lu-octreotide combination treatment in a high-risk neuroblastoma xenograft mouse
model
Arman Romiani, Daniella Pettersson, Klara Simonsson, Hana Bakr, Dan E. Lind, Anikó Kovács, Johan Spetz, Ruth H. Palmer, Bengt Hallberg, Khalil Helou, Eva Forssell-Aronsson
Therapeutics - 2024 -
Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing
mice
Arman Romiani, Klara Simonsson, Daniella Pettersson, Amin Al-awar, Nishte Rassol, Hana Bakr, Dan E. Lind, Ganesh Umapathy, Johan Spetz, Ruth H. Palmer, Bengt Hallberg, Khalil Helou, Eva Forssell-Aronsson
Heliyon - 2024 -
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR
inhibition
Marcus Borenäs, Ganesh Umapathy, Dan E. Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L. Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N. Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H. Palmer
Proceedings of the National Academy of Sciences of the United States of America - 2024 -
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4
expression
Tzu-Po Chuang, Wei-Yun Lai, Jonatan L. Gabre, Dan E. Lind, Ganesh Umapathy, Abdulmalik Bokhari, Bengt Bergman, Linnea Kristenson, Fredrik Bergh Thorén, Anh Le, Robert C. Doebele, Jimmy Van den Eynden, Ruth H. Palmer, Bengt Hallberg
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA - 2023 -
ATR inhibition enables complete tumour regression in ALK-driven NB mouse
models
Joanna Szydzik, Dan E. Lind, Badrul Arefin, Yeshwant Kurhe, Ganesh Umapathy, Joachim T. Siaw, A. Claeys, Jonatan L. Gabre, J. van den Eynden, Bengt Hallberg, Ruth H. Palmer
Nature Communications - 2021 -
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK
mutation.
Marcus Borenäs, Ganesh Umapathy, Wei-Yun Lai, Dan E. Lind, Barbara Witek, Jikui Guan, Patricia Mendoza-García, Tafheem Masudi, Arne Claeys, Tzu-Po Chuang, Abeer El Wakil, Badrul Arefin, Susanne Fransson, Jan Koster, Mathias Johansson, Jennie Gaarder, Jimmy Van den Eynden, Bengt Hallberg, Ruth H. Palmer
The EMBO journal - 2021 -
Neuroblastoma xenograft models demonstrate the therapeutic potential of
Lu-177-octreotate
Arman Romiani, Johan Spetz, Emman Shubbar, Dan E. Lind, Bengt Hallberg, Ruth H. Palmer, Eva Forssell-Aronsson
BMC Cancer - 2021 -
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in
Neuroblastoma
Joachim T. Siaw, Niloufar Javanmardi, Jimmy Van den Eynden, Dan E. Lind, Susanne Fransson, Angela Martinez-Monleon, Anna Djos, Rose-Marie Sjöberg, Malin Östensson, H. Caren, G. Troen, K. Beiske, A. P. Berbegall, R. Noguera, Wei-Yun Lai, P. Kogner, Ruth H. Palmer, Bengt Hallberg, Tommy Martinsson
Cell Reports - 2020